{
  "paper_id": "1832f6c126ee4564a036ee5c45c80b423f3d3fc8",
  "metadata": {
    "title": "Development, Characterization, and Application of Monoclonal Antibodies against Severe Acute Respiratory Syndrome Coronavirus Nucleocapsid Protein á°”",
    "coda_data_split": "test",
    "coda_paper_id": 275,
    "coda_has_expert_labels": false,
    "subset": "custom_license"
  },
  "abstract": [
    {
      "original_text": "Five monoclonal antibodies (MAbs) against recombinant nucleocapsid protein (NP) of severe acute respiratory syndrome (SARS)-causing coronavirus (CoV) were developed by hybridoma technology. Epitope mapping by Western blotting showed that these anti-SARS-CoV NP MAbs bind to distinct domains of NP. These anti-SARS-CoV NP MAbs, with their high specificity, are potentially ideal candidates for developing early and sensitive diagnostic assays for SARS-CoV.",
      "sentences": [
        [
          {
            "segment_text": "Five monoclonal antibodies ( MAbs ) against recombinant nucleocapsid protein ( NP ) of severe acute respiratory syndrome ( SARS ) - causing coronavirus ( CoV ) were developed by hybridoma technology .",
            "crowd_label": "background"
          }
        ],
        [
          {
            "segment_text": "Epitope mapping by Western blotting showed that these anti-SARS-CoV NP MAbs bind to distinct domains of NP .",
            "crowd_label": "background"
          }
        ],
        [
          {
            "segment_text": "These anti-SARS-CoV NP MAbs , with their high specificity ,",
            "crowd_label": "finding"
          },
          {
            "segment_text": "are potentially ideal candidates for developing early and sensitive diagnostic assays for SARS-CoV .",
            "crowd_label": "finding"
          }
        ]
      ]
    }
  ],
  "abstract_stats": {
    "paragraph_num": "1",
    "sentence_num": "3",
    "segment_num": "4",
    "token_num": "75"
  }
}